schedule of services
BCVG has capabilities to drive all aspects of the product development and commercialization process:
Product strategy and definition
Pre-clinical & clinical study design
Portfolio management and
Regulatory strategy submissions
and FDA negotiation
Forecasting and financial modeling
Business strategy and partnering
Reimbursement strategy and
Primary market research (physician and payer surveys and KOL roundtables)
How we leverage
BCVG believes input and perspectives from all operational functions is essential for the creation of cogent business strategies that minimize executional risk.
This holistic approach separates BCVG from many other consulting firms that focus on a single business discipline.
What our client
PARTNERS are saying
Ei Yamada, PhD
CEO, AnGes Inc.
Scott and his team have a wonderful ability to integrate with a wide variety of partners, especially given the great distance and unique culture of our Japanese company. His knowledge and negotiation style with the FDA has been invaluable to our success.
CEO, AgNovos, Inc.
BCVG has been a key contributor to our most important initiatives for over five years. Not only have they helped us navigate the FDA, but their expertise in designing and reviewing animal studies, clinical studies and global data collection has been extraordinary.
CEO, Lipogems S.p.A.
The BCVG Team has become an essential part of our strategic plan, quickly demonstrating the enormous value they provide by addressing every challenge we throw their way.